Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 11/20 | 0.47 |
| ▸ | CASP2 | P42575 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1936229 | 0.98 | EPHX1 (0.45) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| Hydrochloric Acid SCHEMBL1938197 | 0.98 | EPHX1 (0.45) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| Hydrochloric Acid SCHEMBL1938993 | 0.98 | EPHX1 (0.45) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL14868287 | 0.98 | EPHX1 (0.43) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL13227081 | 0.92 | EPHX1 (0.39) | EPHX1 | |
| SCHEMBL28641303 | 0.92 | KDM4E (0.37) | EPHX1CASP2 | |
| SCHEMBL14682771 | 0.92 | EPHX1 (0.54) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL2782596 | 0.92 | EPHX1 (0.54) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL18040458 | 0.92 | EPHX1 (0.54) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL918890 | 0.92 | EPHX1 (0.54) | EPHX1CASP2ZDHHC20ZDHHC2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238331-A1 | COATINGS, FORMULATIONS, USES AND COATING METHODS | BIOINTERACTIONS LTD (GB) | 2024-07-18 | — | — | US | disclosed |
| US-20230338476-A1 | COACTIVE COMBINATIONS OF ANTIMICROBIALS WITH DISPERSINB | ONTARIO POWER GENERATION INC. (CA) | 2023-10-26 | — | — | US | disclosed |
| US-11759441-B2 | Biguanide compositions and methods of treating metabolic disorders | ANJI PHARMACEUTICALS INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-11759441-B2 | Biguanide compositions and methods of treating metabolic disorders | ANJI PHARMACEUTICALS INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-11744248-B2 | Disinfectant composition for control of clostridium difficile spore | ENVIRO SPECIALTY CHEMICALS INC. (US) | 2023-09-05 | — | — | US | disclosed |
| WO-2023159278-A1 | ANTI-PATHOGENIC AEROSOL COMPOSITIONS | Squire Kent Pty Limited (AU) | 2023-08-31 | — | — | WO | disclosed |
| US-RE49528-E1 | Bioactive coatings | BIOINTERACTIONS LTD. (GB) | 2023-05-16 | — | — | US | disclosed |
| US-RE49522-E1 | Bioactive coatings | BIOINTERACTIONS LTD. (GB) | 2023-05-09 | — | — | US | disclosed |
| US-10448643-B2 | Low pH disinfectant composition | MEDIVATORS INC. (US) | 2019-10-22 | — | — | US | disclosed |
| US-10028923-B2 | Biguanide compositions and methods of treating metabolic disorders | ELCELYX THERAPEUTICS, INC. (US) | 2018-07-24 | — | — | US | disclosed |
| US-20110212933-A1 | Antiseptic Compositions for the Treatment of Infections | ALDA PHARMACEUTICALS CORP. (CA) | 2011-09-01 | — | — | US | disclosed |
| US-7851541-B2 | Composition and use | ARCH UK BIOCIDES LIMITED (GB) | 2010-12-14 | — | — | US | disclosed |
| US-20100240762-A1 | SANITIZER FORMULATIONS | ARCH CHEMICALS, INC. | 2010-09-23 | — | — | US | disclosed |
| US-20080142453-A1 | Biocidal composition and method for treating recirculating water systems | ARCH CHEMICALS, INC. | 2008-06-19 | — | — | US | disclosed |
| US-20070271707-A1 | Fibres Treated With Antimicrobial Agents | ARCH UK BIOCIDES LIMITED (GB) | 2007-11-29 | — | — | US | disclosed |
| US-7285157-B1 | Air filter | ARCH UK BIOCIDES LIMITED (GB) | 2007-10-23 | — | — | US | disclosed |
| US-20070203285-A1 | Composition and use | HODGE DAVID J | 2007-08-30 | — | — | US | disclosed |
| US-7226968-B2 | Composition and use | ARCH UK BIOCIDES LIMITED (GB) | 2007-06-05 | — | — | US | disclosed |
| US-7217759-B2 | Composition and use | ARCH UK BIOCIDES LIMITED (GB) | 2007-05-15 | — | — | US | disclosed |
| US-7202287-B2 | Method and compositions | ARCH CHEMICALS, INC. (US) | 2007-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240762-A1 | SANITIZER FORMULATIONS | ACMSD, AADAC, ALKBH5 | EPHX1 4454/4885CASP2 731/4885ZDHHC20 1505/4885 |
| US-20110212933-A1 | Antiseptic Compositions for the Treatment of Infections | CUTA, POLR1C, NACA | EPHX1 2483/4885CASP2 2277/4885ZDHHC20 1118/4885 |
| US-20240238331-A1 | COATINGS, FORMULATIONS, USES AND COATING METHODS | GNE, PUF60, HPSE | EPHX1 3779/4885CASP2 3027/4885ZDHHC20 3034/4885 |
| US-20080142453-A1 | Biocidal composition and method for treating recirculating water systems | DBH, DBF4, QDPR | EPHX1 963/4885CASP2 1607/4885ZDHHC20 3006/4885 |
| US-11744248-B2 | Disinfectant composition for control of clostridium difficile spore | EPCAM, DSTN, DSG1 | EPHX1 4028/4885CASP2 657/4885ZDHHC20 2757/4885 |
| US-11759441-B2 | Biguanide compositions and methods of treating metabolic disorders | SLC5A2, SLC5A1, GPR119 | EPHX1 2097/4885CASP2 3362/4885ZDHHC20 1045/4885 |
| US-10448643-B2 | Low pH disinfectant composition | ADH1C, ADH1A, ADH5 | EPHX1 579/4885CASP2 144/4885ZDHHC20 1734/4885 |
| US-20070271707-A1 | Fibres Treated With Antimicrobial Agents | DCXR, MGAM, COL1A1 | EPHX1 1744/4885CASP2 1010/4885ZDHHC20 3812/4885 |
| US-10028923-B2 | Biguanide compositions and methods of treating metabolic disorders | SLC5A2, SLC5A1, GPR119 | EPHX1 2097/4885CASP2 3362/4885ZDHHC20 1045/4885 |
| US-20230338476-A1 | COACTIVE COMBINATIONS OF ANTIMICROBIALS WITH DISPERSINB | DSTN, DBN1, DBNL | EPHX1 4376/4885CASP2 2683/4885ZDHHC20 3713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.